The lasting misery of coronavirus long-haulers

By: Michael Marshall - 16 Sept, 2020
The lasting misery of coronavirus long-haulers

The lung scans were the first sign of trouble. In the early weeks of the coronavirus pandemic, clinical radiologist Ali Gholamrezanezhad began to notice that some people who had cleared their COVID-19 infection still had distinct signs of damage. “Unfortunately, sometimes the scar never goes away,” he says.

Gholamrezanezhad, at the University of Southern California in Los Angeles, and his team started tracking patients in January using computed tomography (CT) scanning to study their lungs. They followed up on 33 of them more than a month later, and their as-yet-unpublished data suggest that more than one-third had tissue death that has led to visible scars. The team plans to follow the group for several years.

These patients are likely to represent the worst-case scenario. Because most infected people do not end up in hospital, Gholamrezanezhad says the overall rate of such intermediate-term lung damage is likely to be much lower — his best guess is that it is less than 10%. Nevertheless, given that 28.2 million people are known to have been infected so far, and that the lungs are just one of the places that clinicians have detected damage, even that low percentage implies that hundreds of thousands of people are experiencing lasting health consequences.

Doctors are now concerned that the pandemic will lead to a significant surge of people battling lasting illnesses and disabilities. Because the disease is so new, no one knows yet what the long-term impacts will be. Some of the damage is likely to be a side effect of intensive treatments such as intubation, whereas other lingering problems could be caused by the virus itself. But preliminary studies and existing research into other coronaviruses suggest that the virus can injure multiple organs and cause some surprising symptoms.

People with more severe infections might experience long-term damage not just in their lungs, but in their heart, immune system, brain and elsewhere. Evidence from previous coronavirus outbreaks, especially the severe acute respiratory syndrome (SARS) epidemic, suggests that these effects can last for years.

And although in some cases the most severe infections also cause the worst long-term impacts, even mild cases can have life-changing effects — notably a lingering malaise similar to chronic fatigue syndrome.

Many researchers are now launching follow-up studies of people who had been infected with SARS-CoV-2, the virus that causes COVID-19. Several of these focus on damage to specific organs or systems; others plan to track a range of effects. In the United Kingdom, the Post-Hospitalisation COVID-19 Study (PHOSP-COVID) aims to follow 10,000 patients for a year, analysing clinical factors such as blood tests and scans, and collecting data on biomarkers. A similar study of hundreds of people over 2 years launched in the United States at the end of July.

What they find will be crucial in treating those with lasting symptoms and trying to prevent new infections from lingering. “We need clinical guidelines on what this care of survivors of COVID-19 should look like,” says Nahid Bhadelia, an infectious-diseases clinician at Boston University School of Medicine in Massachusetts, who is setting up a clinic to support people with COVID-19. “That can’t evolve until we quantify the problem.”

Enduring effects
In the first few months of the pandemic, as governments scrambled to stem the spread by implementing lockdowns and hospitals struggled to cope with the tide of cases, most research focused on treating or preventing infection.

Doctors were well aware that viral infections could lead to chronic illness, but exploring that was not a priority. “At the beginning, everything was acute, and now we’re recognizing that there may be more problems,” says Helen Su, an immunologist at the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland. “There is a definite need for long-term studies.”

The obvious place to check for long-term harm is in the lungs, because COVID-19 begins as a respiratory infection. Few peer-reviewed studies exploring lasting lung damage have been published. Gholamrezanezhad’s team analysed lung CT images of 919 patients from published studies and found that the lower lobes of the lungs are the most frequently damaged. The scans were riddled with opaque patches that indicate inflammation, that might make it difficult to breathe during sustained exercise. Visible damage normally reduced after two weeks1. An Austrian study also found that lung damage lessened with time: 88% of participants had visible damage 6 weeks after being discharged from hospital, but by 12 weeks, this number had fallen to 56% (see go.nature.com/3hiiopi).

Animated sequence of lung scans from a recovered COVID-19 patient over twelve weeks after leaving hospital

Lung scans from a 50-year-old show that damage from COVID-19 (red) can improve with time — but many patients have lasting symptoms.Credit: Prof. Gerlig Widmann, Dr. Christoph Schwabl, Dr. Anna Luger - Dpt. of Radiology, Innsbruck Medical University.

Symptoms might take a long time to fade; a study2 posted on the preprint server medRxiv in August followed up on people who had been hospitalized, and found that even a month after being discharged, more than 70% were reporting shortness of breath and 13.5% were still using oxygen at home.

Evidence from people infected with other coronaviruses suggests that the damage will linger for some. A study3 published in February recorded long-term lung harm from SARS, which is caused by SARS-CoV-1. Between 2003 and 2018, Peixun Zhang at Peking University People’s Hospital in Beijing and his colleagues tracked the health of 71 people who had been hospitalized with SARS. Even after 15 years, 4.6% still had visible lesions on their lungs, and 38% had reduced diffusion capacity, meaning that their lungs were poor at transferring oxygen into the blood and removing carbon dioxide from it.

COVID-19 often strikes the lungs first, but it is not simply a respiratory disease, and in many people, the lungs are not the worst-affected organ. In part, that’s because cells in many different locations harbour the ACE2 receptor that is the virus’s major target, but also because the infection can harm the immune system, which pervades the whole body.

Some people who have recovered from COVID-19 could be left with a weakened immune system. Many other viruses are thought to do this. “For a long time, it’s been suggested that people who have been infected with measles are immunosuppressed in an extended period and are vulnerable to other infections,” says Daniel Chertow, who studies emerging pathogens at the National Institutes of Health Clinical Center in Bethesda, Maryland. “I’m not saying that would be the case for COVID, I’m just saying there’s a lot we don’t know.” SARS, for instance, is known to decrease immune-system activity by reducing the production of signalling molecules called interferons.

Su and her colleagues hope to enrol thousands of people worldwide in a project called the COVID Human Genetic Effort, which aims to find genetic variants that compromise people’s immune systems and make them more vulnerable to the virus. They plan to expand the study to those with long-term impairment, hoping to understand why their symptoms persist and to find ways to help them. “Someone who has prolonged problems, beyond what would be normally seen, they would be of interest to study,” says Su.

The virus can also have the opposite effect, causing parts of the immune system to become overactive and trigger harmful inflammation throughout the body. This is well documented in the acute phase of the illness, and is implicated in some of the short-term impacts. For instance, it might explain why a small number of children with COVID-19 develop widespread inflammation and organ problems.

This immune over-reaction can also happen in adults with severe COVID-19, and researchers want to know more about the knock-on effects after the virus has run its course. “It seems there’s a lag there for it to get hold of the person and then cause this severe inflammation,” says Adrienne Randolph, a senior associate in critical-care medicine at Boston Children’s Hospital. “But then the thing is that, long term, when they recover, how long does it take the immune system to settle back to normality?”

Heart of the matter
An over-reactive immune system can lead to inflammation, and one particularly susceptible organ is the heart. During the acute phase of COVID-19, about one-third of patients show cardiovascular symptoms, says Mao Chen, a cardiologist at Sichuan University in Chengdu, China. “It’s absolutely one of the short-term consequences.”

One such symptom is cardiomyopathy, in which the muscles of the heart become stretched, stiff or thickened, affecting the heart’s ability to pump blood. Some patients also have pulmonary thrombosis, in which a clot blocks a blood vessel in the lungs. The virus can also injure the wider circulatory system, for instance, by infecting the cells lining blood vessels5.

CT chest of a 44-year-old man with COVID-19, who returned for follow-up imaging 34 days after the initial presentation

Lung damage (opaque white patch, lower left) can persist for weeks after the initial infection.Credit: Ali Gholamrezanezhad

“My major concern is also the long-term impact,” says Chen. In some patients, he says, the risk to the cardiovascular system “lingers for a long time”. Chen and his colleagues reviewed data from before the pandemic for a study6 published in May, noting that people who have had pneumonia are at increased risk of cardiovascular disease 10 years later — although the absolute risk is still small. Chen speculates that an over-reactive immune system, and the resulting inflammation, might be involved. However, there is little information on long-term cardiovascular harms from SARS or the related disease Middle Eastern respiratory syndrome (MERS), let alone from SARS-CoV-2.

Studies are now starting. At the beginning of June, the British Heart Foundation in London announced six research programmes, one of which will follow hospitalized patients for six months, tracking damage to their hearts and other organs. Data-sharing initiatives such as the CAPACITY registry, launched in March, are compiling reports from dozens of European hospitals about people with COVID-19 who have cardiovascular complications.

Similar long-term studies are needed to understand the neurological and psychological consequences of COVID-19. Many people who become severely ill experience neurological complications such as delirium, and there is evidence that cognitive difficulties, including confusion and memory loss, persist for some time after the acute symptoms have cleared. But it is not clear whether this is because the virus can infect the brain, or whether the symptoms are a secondary consequence — perhaps of inflammation.

Chronic fatigue
One of the most insidious long-term effects of COVID-19 is its least understood: severe fatigue. Over the past nine months, an increasing number of people have reported crippling exhaustion and malaise after having the virus. Support groups on sites such as Facebook host thousands of members, who sometimes call themselves “long-haulers”. They struggle to get out of bed, or to work for more than a few minutes or hours at a time. One study7 of 143 people with COVID-19 discharged from a hospital in Rome found that 53% had reported fatigue and 43% had shortness of breath an average of 2 months after their symptoms started. A study of patients in China showed that 25% had abnormal lung function after 3 months, and that 16% were still fatigued.

Paul Garner, a infectious-disease researcher at the Liverpool School of Tropical Medicine, UK, has experienced this at first hand. His initial symptoms were mild, but he has since experienced “a roller coaster of ill health, extreme emotions and utter exhaustion”. His mind became “foggy” and new symptoms cropped up almost every day, ranging from breathlessness to arthritis in his hands.

These symptoms resemble chronic fatigue syndrome, also known as myalgic encephalomyelitis (ME). The medical profession has struggled for decades to define the disease — leading to a breakdown of trust with some patients. There are no known biomarkers, so it can only be diagnosed based on symptoms. Because the cause is not fully understood, it is unclear how to develop a treatment. Dismissive attitudes from doctors persist, according to some patients.

People reporting chronic fatigue after having COVID-19 describe similar difficulties. In the forums, many long-haulers say they have received little or no support from doctors — perhaps because many of them showed only mild symptoms, or none at all, and were never hospitalized or in danger of dying. It will not be easy to establish the links between COVID-19 and fatigue with certainty, says Randolph. Fatigue does not seem to be limited to severe cases. It is common in people who had mild symptoms and who therefore might not have been tested for the virus.

The only way to find out whether SARS-CoV-2 is behind these symptoms is to compare people known to have had the virus with those who have not, says Chertow, to see how often fatigue manifests and in what form. Otherwise there is a risk of lumping together people whose fatigue has manifested for different reasons, and who might need distinct treatments.

Chertow says he is not aware of such a study for COVID-19, but they have been done for other diseases. Following the Ebola epidemic in West Africa in 2014–16, US researchers collaborated with the Ministry of Health in Liberia to perform a long-term follow-up study9 called Prevail III. The study identified six long-term impacts from Ebola, ranging from joint pain to memory loss. Bhadelia, who treated hundreds of people with Ebola during the outbreak, says that these post-viral symptoms had not previously been recognized. Usually, she says, “we don’t stick around past the acute stage. We don’t look at the long tail of recovery. It’s important to do that, because it tells you more about the virus and its pathophysiology.”

The situation is clearer for people who have been severely ill with COVID-19, especially those who ended up on ventilators, says Chertow. In the worst cases, patients experience injury to muscles or the nerves that supply them, and often face “a really long-fought battle on the order of months or up to years” to regain their previous health and fitness, he says. He and his colleagues are now recruiting people with COVID-19 from across the severity spectrum for a long-term follow-up study, assessing their brains, lungs, hearts, kidneys and inflammation responses while they are acutely ill, then during recovery a few weeks later, and again after 6–12 months (see go.nature.com/3mfqqxc).

Once again, there is evidence from SARS that coronavirus infection can cause long-term fatigue. In 2011, Harvey Moldofsky and John Patcai at the University of Toronto in Canada described 22 people with SARS, all of whom remained unable to work 13–36 months after infection10. Compared with matched controls, they had persistent fatigue, muscle pain, depression and disrupted sleep. Another study11, published in 2009, tracked people with SARS for 4 years and found that 40% had chronic fatigue. Many were unemployed and had experienced social stigmatization.

It is not clear how viruses might do this damage, but a 2017 review12 of the literature on chronic fatigue syndrome found that many patients have persistent low-level inflammation, possibly triggered by infection.

If COVID-19 is such a trigger, a wave of psychological effects “may be imminent”, write a group of researchers led by Declan Lyons, a psychiatrist at St Patrick’s Mental Health Services in Dublin13. The ME Association, a UK-based charity, says it has received many reports of previously healthy people whose energy levels have not returned to normal after becoming infected with the virus, and expects to see new cases of chronic fatigue syndrome. In many countries, the pandemic shows no sign of waning, and health systems are already at capacity responding to acute cases. Nevertheless, researchers say it is crucial to start digging into the long-term effects now.

But the answers will not come quickly. “The problem is,” says Gholamrezanezhad, “to assess long-term consequences, the only thing you need is time.”

(This story has not been edited by VOH and is auto-generated from a syndicated feed.)

suggested Tags

Subscribe Our Newsletter

Pfizer, BioNTech start combined trials of COVID-19 vaccine candidate in Japan
By: Reuters - 20 Oct, 2020

News

Pfizer, BioNTech start combined trials o

By: Reuters-20 Oct, 2020

Coronavirus and diabetes: What you need

By: Staff Writer-20 Oct, 2020

India records 46,790 new COVID-19 cases

By: PTI-20 Oct, 2020

50% Indians are likely to have Covid by

By: Reuters-20 Oct, 2020

Living coronavirus found on frozen food

By: PTI-19 Oct, 2020

Getting vaccine doubters to roll up thei

By: Reuters-19 Oct, 2020

Latest on the worldwide spread of corona

By: Reuters-19 Oct, 2020

AstraZeneca wins two approval recommenda

By: Reuters-19 Oct, 2020

With dip in air quality in Delhi, health

By: ANI-19 Oct, 2020

Global coronavirus cases surpass the 40

By: Reuters-19 Oct, 2020

Pan-India covid-19 genome studies sugges

By: PTI-18 Oct, 2020

Health expert asserts on N95 mask withou

By: Joymala Bagchi , ANI.-18 Oct, 2020

Coronavirus survives on skin five times

By: AFP-18 Oct, 2020

Treat coronavirus early to save patients

By: Jason Gale , Bloomberg-18 Oct, 2020

Long COVID 'May Be Four Syndromes'

By: Peter Russell-17 Oct, 2020

WHO trial to assess other antibody, anti

By: Reuters-17 Oct, 2020

Scientists develop new method to block c

By: PTI-17 Oct, 2020

Sinovac coronavirus vaccine offered by C

By: Reuters-17 Oct, 2020

India's COVID-19 infection tally crosses

By: PTI-17 Oct, 2020

SARS-CoV-2 may use key carbohydrate to i

By: Erin Bryant-16 Oct, 2020

20% Rise In Death Rate Mostly Because of

By: Kathleen Doheny-16 Oct, 2020

COVID-19 Doesn’t Seem Seasonal, St

By: Carolyn Crist-16 Oct, 2020

Can Vitamin D treat coronavirus? UK scie

By: Meghna Sen-16 Oct, 2020

WHO trial results show remdesivir has li

By: Leroy Leo-16 Oct, 2020

COVID-19 caseload in India rises to 73,7

By: PTI-16 Oct, 2020

A healthy young person might have to wai

By: Staff Writer-15 Oct, 2020

Important that Russia's Covid-19 vaccine

By: ANI-15 Oct, 2020

COVID-19 caseload in India rises to 72,3

By: PTI-14 Oct, 2020

Aarogya Setu app helped identify coronav

By: Meghna Sen-14 Oct, 2020

World Bank approves $12 billion for covi

By: AFP-14 Oct, 2020

Eli Lilly pauses Covid-19 antibody treat

By: AFP-14 Oct, 2020

New Zealand signs deal with Pfizer, Bi

By: Reuters-12 Oct, 2020

Less than 1000 coronavirus deaths reco

By: PTI-12 Oct, 2020

Covid-19 vaccines under different trial

By: Sangeeta Ojha-12 Oct, 2020

Maintain quality testing for Covid-19 ki

By: ANI-12 Oct, 2020

Maintain quality testing for Covid-19 ki

By: ANI-12 Oct, 2020

COVID research updates: Dense cities sho

By: Anonymous-12 Oct, 2020

Coronavirus risk may go up on exposure t

By: ANI-12 Oct, 2020

UK to begin trials to test if BCG vaccin

By: PTI-12 Oct, 2020

Inhaled vaccines aim to fight coronaviru

By: Bloomberg-12 Oct, 2020

U.S., AstraZeneca strike deal for COVID-

By: Heidi Ledford & Ewen Callaway-10 Oct, 2020

Covid-19 Story Tip: Biomedical Engineers

By: Elizabeth Logsdon, Ph.D., and Warren Grayson, Ph.D./Johns Hopkins Medicine-10 Oct, 2020

India reports 73,272 new coronavirus cas

By: PTI-10 Oct, 2020

COVID-19 vaccine: Russia all set to appr

By: Anulekha Ray-10 Oct, 2020

COVID-19 treatment: Regeneron's antibody

By: Mint Agencies-10 Oct, 2020

Gilead's remdesivir shaved five days off

By: Reuters-09 Oct, 2020

COVID-19 treatment: After Lilly, Fosun u

By: Reuters-09 Oct, 2020

COVID + flu nasal spray vaccine set to s

By: Bloomberg-09 Oct, 2020

Moderna to apply for EU's rolling approv

By: Staff Writer-09 Oct, 2020

Virologists who discovered hepatitis C w

By: Ewen Callaway & Heidi Ledford-08 Oct, 2020

Pioneers of revolutionary CRISPR gene ed

By: Heidi Ledford & Ewen Callaway-08 Oct, 2020

COVID-19 cases in India cross 68-lakh ma

By: PTI-08 Oct, 2020

COVID-19 treatment: Lilly seeks emergenc

By: Staff Writer-08 Oct, 2020

India declines proposal to test Russia C

By: Reuters-08 Oct, 2020

Asthma patients less likely to die from

By: Reuters-08 Oct, 2020

Government to launch Ayurveda and Yoga p

By: Rhythma Kaul, Hindustan Times New Delhi-07 Oct, 2020

COVID-Linked Syndrome Seen in Kids Found

By: Anonymous-07 Oct, 2020

Single-day spike of 61,267 COVID-19 infe

By: PTI-07 Oct, 2020

HIV treatment has no benefit for hospita

By: Reuters-07 Oct, 2020

Doctors consider anti-cancer drugs as a

By: Neetu Chandra Sharma-07 Oct, 2020

CDC issues latest guidance on covid-19 s

By: LiveMint-07 Oct, 2020

Covid-19 to place greater demand on ment

By: Neetu Chandra Sharma-07 Oct, 2020

COVID research updates: Massive contact-

By: Sonu Mehta/Hindustan Times/Getty-05 Sept,2020

COVID-19 cases in India breach 66-lakh m

By: PTI-05 Oct, 2020

Can cancer drugs prove helpful in treati

By: Neetu Chandra Sharma-05 Oct, 2020

Researchers develop new Covid-19 test th

By: PTI-05 Oct, 2020

MHFI and AIIMS doctors launch web portal

By: ANI-05 Oct, 2020

Pandemic, new platforms prompt surge in

By: Anne Steele , The Wall Street Journal-05 Oct, 2020

How long could I be contagious before a

By: AP News-04 Oct, 2020

Single-day COVID-19 cases in India below

By: PTI-04 Oct, 2020

Research Story Tip: Study Finds Obesity

By: Newsroom-04 Oct, 2020

Research Story Tip: Temperature-Sensitiv

By: Newsroom-04 Oct, 2020

COVID-19 cases in India breach 65-lakh m

By: PTI-04 Oct, 2020

Covid-19 vaccines should first go to hea

By: The Wall Street Journal-04 Oct, 2020

Why A Negative Test Doesn't Rule Out COV

By: Brenda Goodman, MA-04 Oct, 2020

Pain relief caused by coronavirus may he

By: PTI-03 Oct, 2020

Dr Reddy's seeks DCGI nod to conduct pha

By: PTI-03 Oct, 2020

Oxford covid vaccine: Canada launches re

By: Reuters-03 Oct, 2020

How long a person could contagious befor

By: AP News-03 Oct, 2020

'Superspreaders' Are Driving the COVID-1

By: Ralph Ellis-03 Oct, 2020

Neanderthal genes linked with severe COV

By: Reuters-02 Oct, 2020

Gene mutation behind difference in COVID

By: PTI-02 Oct, 2020

Startup bets on new coronavirus testing

By: Bloomberg-02 Oct, 2020

Mosquitoes cannot transmit the coronavir

By: Reuters-02 Oct, 2020

India's COVID-19 tally comes close to 64

By: PTI-02 Oct, 2020

The race for COVID-19 vaccine: Why this

By: Bloomberg-02 Oct, 2020

Latest on the worldwide spread of corona

By: Reuters-30 Sept, 2020

India's COVID-19 caseload races past 62

By: PTI-30 Sept, 2020

COVID-19 Vaccine Trial Shows Promise for

By: Brenda Goodman, MA-30 Sept, 2020

Coronavirus may deplete testosterone lev

By: PTI-30 Sept, 2020

Russia to supply 2.5 crore doses of covi

By: Agencies-30 Sept, 2020

Moderna COVID vaccine: Early study shows

By: Reuters-30 Sept, 2020

Tests reveal silent reinfections in hosp

By: Sonu Mehta/Hindustan Times via Getty-29 Sept, 2020

Can the coronavirus spread through the a

By: AP-29 Sept, 2020

Covid vaccine: Russia may be the first t

By: Polina Nikolskaya , Polina Ivanova , Reuters-29 Sept, 2020

Russia to supply 2.5 crore doses of covi

By: livemint-29 Sept, 2020

COVID tally crosses 60 lakh; 1,039 more

By: PTI-28 Sept, 2020

Covid-19: A cheaper, faster, accurate te

By: ANI-28 Sept, 2020

Phase III trials of Sputnik V critical t

By: Neetu Chandra Sharma-28 Sept, 2020

Researchers combine heat and humidity to

By: PTI-26 Sept, 2020

FDA Authorizes Point-of-Care COVID Antib

By: Carolyn Crist-26 Sept, 2020

Novavax initiates late-stage covid-19 va

By: Reuters-26 Sept, 2020

India's COVID vaccine: Phase-3 trial of

By: Staff Writer-26 Sept, 2020

WHO backed China for emergency use of CO

By: PTI-26 Sept, 2020

Johnson and Johnson COVID vaccine shows

By: ANI-26 Sept, 2020

Covid vaccine: Pfizer urged to wait for

By: Bloomberg-26 Sept, 2020

COVID-19 May Damage Blood Marrow Immune

By: Carolyn Crist-25 Sept, 2020

How can I tell the difference between th

By: AP News-25 Sept, 2020

COVID-19 vaccine: UP govt allows Covaxin

By: PTI-25 Sept, 2020

Some Covid-19 patients show signs of hea

By: Sarah Toy , The Wall Street Journal-25 Sept, 2020

Can I use a face shield instead of a mas

By: AP News-25 Sept, 2020

Dengue vaccine: Panacea Biotec seeks rev

By: PTI-25 Sept, 2020

Covid-19: Daily recoveries exceed daily

By: PTI-25 Sept, 2020

COVID-19 cases in India breach 57-lakh m

By: PTI-25 Sept, 2020

COVID-19 tally in India crosses 56-lakh

By: PTI-24 Sept, 2020

U.S. FDA to tighten coronavirus vaccine

By: Reuters-24 Sept, 2020

Many Metrics to Measure COVID-19, Which

By: Christine Lehmann, MA-24 Sept, 2020

DCGI issues guidelines for pharma giants

By: ANI-23 Sept, 2020

EPA Adds to List of Coronavirus-Fighting

By: Jay Croft-22 Sept, 2020

Coronavirus vaccine makers see EU shield

By: Francesco Guarascio-22 Sept, 2020

Flu jab 'more important than ever' this

By: Michelle Roberts-22 Sept, 2020

Tracking COVID-19 with wastewater.

By: David A. Larsen & Krista R. Wigginton-22 Sept, 2020

Coronavirus vaccine likely to be ready f

By: Bloomberg-22 Sept, 2020

Influenza vaccine does not increase Covi

By: Reuters-22 Sept, 2020

Coronavirus grows less deadly as doctors

By: Bloomberg-21 Sept, 2020

86,961 new COVID-19 cases in India, tall

By: PTI-21 Sept, 2020

WHO endorses protocol for coronavirus he

By: AFP-21 Sept, 2020

TCS sets up 11 coronavirus isolation cen

By: PTI-21 Sept, 2020

Oxford covid vaccine: AstraZeneca denies

By: Bloomberg-18 Sept, 2020

Government to use immunisation program m

By: Leroy Leo-18 Sept, 2020

Oxford COVID-19 vaccine: Serum Institute

By: Anulekha Ray-19 Sept, 2020

WHO endorses protocol for coronavirus he

By: REUTERS-20 Sept, 2020

When will COVID-19 vaccines be generally

By: Reuters-18 Sept, 2020

COVID Conflicts Are Straining Relationsh

By: Serena Gordon-18 Sept, 2020

COVID Prevention May Mean Record Low Flu

By: Dennis Thompson-18 Sept, 2020

Coffee May Slow Spread of Colon Cancer

By: Alan Mozes-18 Sept, 2020

Rich nations have cornered half of futur

By: AFP-18 Sept, 2020

Oxford covid vaccine: AstraZeneca denies

By: Bloomberg-18 Sept, 2020

Centre approved anti-viral medicines to

By: PTI-17 Sept, 2020

Record 97,894 infections pushes India's

By: PTI-17 Sept, 2020

Can a Parkinson's Drug Treat Macular Deg

By: Serena McNiff-17 Sept, 2020

US emergency approval broadens use of Gi

By: PTI-17 Sept 2020

The poisonous history of chemotherapy

By: Heidi Ledford-16 Sept, 2020

Researchers highlight ‘questionabl

By: Alison Abbott-16 Sept, 2020

The lasting misery of coronavirus long-h

By: Michael Marshall-16 Sept, 2020

Post COVID-19, Lung Function Improves Ov

By: Carolyn Crist-16 Sept, 2020

Stillbirth rate rises dramatically durin

By: Clare Watson-16 Sept, 2020

When will there be a cure for covid? The

By: Michelle Cortez , Bloomberg-15 Sept, 2020

Pfizer’s COVID Vaccine Could Be Gi

By: Anonymous-15 Sept, 2020

Scientists relieved as coronavirus vacci

By: David Cyranoski & Smriti Mallapaty-15 Sept, 2020

China coronavirus vaccine may be ready f

By: Reuters-15 Sept, 2020

Latest on the worldwide spread of corona

By: Reuters-15 Sept, 2020

Bill Gates: ‘The next big question

By: Noah Higgins-Dunn & Christina Farr-15 Sept, 2020

Gilead CEO: We’re studying new way

By: Kevin Stankiewicz-15 Sept, 2020

Business leaders push for inclusivity af

By: Sam Shaed-15 Sept, 2020

Scientists publish images of coronavirus

By: PTI-14 Sept, 2020

How pharma companies can still deliver a

By: Anonymous-13 Sept, 2020

China starts testing world's first nasal

By: Anonymous-13 Sept, 2020

Over 1 lakh health IDs created under Nat

By: Anonymous-13 Sept, 2020

Internet searches for symptoms can revea

By: Anonymous-13 Sept, 2020

Oxford covid-19 vaccine: AstraZeneca mus

By: Anonymous-12 Sept 2020

Oxford-AstraZeneca covid vaccine trials

By: Anonymous-12 Sept 2020

Russia Begins Rollout of COVID-19 Vaccin

By: Ralph Ellis-12 Sept 2020

Coronavirus research updates: Surprise!

By: Anonymous-12 Sept 2020

Scientists Identify New Way to Target So

By: Newsroom-12 Sept 2020

COVID-19 Story Tip: Researchers Expect V

By: Newsroom-12 Sept 2020

Oxford covid-19 vaccine: AstraZeneca m

By: Mint News-10 Sep 2020

Can Plexiglass Stop COVID?

By: Kathleen Doheny-08 Sept 2020

Companies testing vaccines pledge safety

By: Linda A. Johnson-08 Sept 2020

Coronavirus research updates: The immune

By: Nature-09 Sept 2020

AstraZeneca COVID-19 vaccine study pause

By: Lauran Neergaard-09,Sept, 2020

India considering Russia's request for P

By: Surajit Dasgupta-08, Sept, 2020

Trial Tests MMR Vaccine to Help Prevent

By: HealthDay Reporter-04 Sept2 020

India's COVID-19 infection tally crosses

By: PTI-08 Sept, 2020

How to fight the deadly dengue virus? Ma

By: Jon Emont , The Wall Street Journal-08 Sept, 2020

Health-Care Startup Ro Raises $200 Milli

By: John McCormick-08 Sept, 2020

The Latest: Australia OKs funding for tw

By: The Associated Press-08 Sept, 2020

UNICEF to lead global procurement, suppl

By: PTI-08 Sept, 2020

UN: No vaccine to be endorsed before it&

By: AP News-08 Sept, 2020

Transplanted brown-fat-like cells hold p

By: Joslin Diabetes Center-05 Sept, 2020

Russia covid vaccine produces immune res

By: Suzi Ring , Bloomberg-05 Sept, 2020

Covid-19 vaccine developers prepare join

By: Peter Loftus-05 Sept, 2020

COVID-19 Ills No Greater for Those With

By: Robert Preidt-05 Sept, 2020

Asthma May Not Boost Odds of Severe COVI

By: Serena Gordon-05 Sept, 2020

Study Backs Use of Saliva COVID-19 Test

By: Kerry Dooley Young-05 Sept, 2020

Coronavirus research updates: Powerful n

By: Anonymous-05 Sept, 2020

Can COVID-19 Cause Diabetes?

By: Anonymous-04 Sept, 2020

‘CRISPR babies’ are still to

By: Heidi Ledford-04 Sept, 2020

Study: COVID-19 Antibodies May Last 4 Mo

By: WEBMD NEWS BRIEF-04 Sept, 2020

Why A Vaccine Won’t Be a Quick Fix

By: Brenda Goodman, MA-04 Sept, 2020

Tiny Biological Package Gets Drug Right

By: Newsroom-04 Sept, 2020

India's COVID-19 tally crosses 38-lakh m

By: PTI-3 Sept, 2020

Steroids can save lives of critically il

By: Kate Kelland , Reuters-3 Sept, 2020

India will supply coronavirus vaccines t

By: Gayathri Vaidyanathan-03 Sept, 2020

Advisory Group Outlines COVID-19 Vaccine

By: Carolyn Crist-2 Sept, 2020

Covid-19 hit cancer research, funding fo

By: Neetu Chandra Sharma-2 Sept, 2020

Brain Cell Death in ALS, Dementia Tied t

By: Newsroom-2 Sept, 2020

Coronavirus research updates: Even octog

By: Anonymous-2 Sept, 2020

Effective Cancer Immunotherapy Further L

By: Newsroom-2 Sept, 2020

Study reveals immune-system deviations i

By: BRUCE GOLDMAN-2 Sept, 2020

Cancer Cells Take Over Blood Vessels to

By: Newsroom-2 Sept, 2020

Research Story Tip: Motor Learning Proce

By: Newsroom-2 Sept, 2020

GSK, partner Vir join race to find COVID

By: Reuters-1 Sep, 2020

COVID-19 can wipe out health care progre

By: Reuters-1 Sep, 2020

Scientists see downsides to top COVID-19

By: Reuters-1 Sep, 2020

Russia to vaccinate high risk groups aga

By: Reuters-1 Sep, 2020

Explainer: How common cold viruses are b

By: Reuters-1 Sep, 2020

Why deforestation and extinctions make p

By: Jeff Tollefson-1 Sep, 2020

What you need to know about the coronavi

By: Reuters-1 Sep, 2020

Antibody therapies could be a bridge to

By: Heidi Ledford-1 Sep, 2020

FDA commissioner says willing to fast-tr

By: Reuters-30 Aug, 2020

Mutated coronavirus strain found in Indo

By: Reuters-30 Aug, 2020

Research Story Tip: Addition by Division

By: Reuters-18 Aug, 2020

Fad or future? Telehealth expansion eyed

By: Ricardo Alonso-Zaldivar-30 Aug, 2020

India sets global record with single-day

By: Reuters-30 Aug, 2020

Global coronavirus cases surpass 25 mill

By: Reuters-30 Aug, 2020

Exclusive: WHO sweetens terms to join st

By: Reuters-29 Aug, 2020

Moderna in talks with Japan to supply 40

By: Reuters-29 Aug, 2020

The coronavirus is most deadly if you ar

By: Smriti Mallapaty-29 Aug, 2020

Got Fatigue? Study Further Pinpoints Bra

By: Newsroom-29 Aug, 2020

J&J to start mid-stage coronavir

By: Reuters-29 Aug, 2020

Latest on the worldwide spread of corona

By: Reuters-29 Aug, 2020

New reckoning for WHO vaccine plan as go

By: Reuters-29 Aug, 2020

How India's Silicon Valley saw its COVID

By: Sachin Ravikumar, Derek Francis, Nivedita Bhattacharjee-26 Aug, 2020

Coronavirus research updates: Sex differ

By: Reuters-26 Aug, 2020

From ACTH to DNA: the rise of acronyms i

By: Giorgia Guglielmi-21 Aug, 2020

COVID-19 Story Tip: Patient Previously D

By: Reuters-25 Aug, 2020

Why IIT Alumni Council withdraws from de

By: Anulekha Ray-24 Aug, 2020

Russia In Touch With India To Manufactur

By: All India | ANI-26 Aug, 2020

COVID-19 lockdowns blocked flu in some p

By: Andrew Meldrum, Mogomotsi Magome and Lauran Neergaard-26 Aug, 2020

Cambridge university aims for autumn tri

By: LONDON (Reuters)-26 Aug, 2020

Treating Wet Age-Related Macular Degener

By: Dr. Eric Nudleman-25 Aug, 2020

Scientists decode how lungs are damaged

By: PTI-25 Aug, 2020

Serum Institute clarifies on report of c

By: LiveMint-25 Aug, 2020

Takeda to sell Japan consumer health uni

By: Junko Fujita-25 Aug, 2020

Survey finds most Britons reject COVID-1

By: Reuters-25 Aug, 2020

U.S. FDA authorizes use of blood plasma

By: Nandita Bose, Aram Roston-25 Aug, 2020

Coronavirus Updates: Manohar Lal Khattar

By: FP Staff-25 Aug, 2020

Study Adds to Evidence That Odor-Sensing

By: Newsroom-24 Aug, 2020

Covid-19 vaccine update: Pfizer, BioNTec

By: FE Online-24 Aug, 2020

Covid-19 vaccine update: Cuba, N Korea,

By: FE Online-24 Aug, 2020

COVID-19 recovery rate reaches 74.69 per

By: PTI-24 Aug, 2020

COVID-19 caseload in India crosses 30-la

By: PTI-24 Aug, 2020

Factbox: Latest on the worldwide spread

By: Reuters-24 Aug, 2020

India crosses crucial milestone of testi

By: PTI-23 Aug, 2020

COVID-19 diagnostic test: Saliva-based t

By: FE Online-23 Aug, 2020

COVID-19: India adds nearly 70,000 cases

By: FE Online-23 Aug, 2020

Novartis immuno-oncology drug candidate

By: Reuters-23 Aug, 2020

US FDA-approved ointment found to treat,

By: PTI-23 Aug, 2020

Trump says without proof that FDA 'deep

By: Reuters-23 Aug, 2020

Coronavirus Updates: Maharashtra reports

By: FP Staff-21 Aug, 2020

Russia's 'Sputnik V' COVID-19 vaccine to

By: Reuters-21 Aug, 2020

Asia Today: India has record high of 69,

By: AP-21 Aug, 2020

Endless first wave: how Indonesia failed

By: Reuters-21 Aug, 2020

Diagnostics firms eye consolidation

By: livemint-21 Aug, 2020

Accuracy Problems with Widely Used Coron

By: Associated Press-21 Aug, 2020

Coronavirus is Not Ready to Budge, So Wh

By: N C Satpathy-20 Aug, 2020

What Is Digital Health ID? Here’s

By: Jagmeet Singh-20 Aug, 2020

How Much Vitamin C Is Too Much Vitamin C

By: Rupali Dutta-20 Aug, 2020

One in four Indians could have been infe

By: Savio Shetty-20 Aug, 2020

Roche, Regeneron link up on COVID-19 ant

By: Reuters-19 Aug, 2020

Explainer: World Health Organization's s

By: Reuters-19 Aug, 2020

Australia hails vaccine deal as virus su

By: Reuters-19 Aug, 2020

COVID-19: Govt to review guidelines to s

By: FE Online-19 Aug, 2020

Coronavirus vaccine update: India begins

By: FE Online-19 Aug, 2020

Immune response after mild COVID-19 is p

By: Reuters-19 Aug, 2020

Recovered cases 2.93 times the number of

By: livemint-19 Aug, 2020

Study links COVID-19 to rise in childhoo

By: Reuters-19 Aug, 2020

WHO blasts 'vaccine nationalism' in last

By: Reuters-19 Aug, 2020

Novavax begins mid-stage study of COVID-

By: Reuters-18 Aug, 2020

COVID-19 vaccine: Do vaccines need to be

By: FE Online-18 Aug, 2020

Russia to roll out vaccine by end of Aug

By: Financial Express-18 Aug, 2020

Testing of CanSino's COVID-19 candidate

By: Reuters-18 Aug, 2020

COVID-19 warriors will be first to get v

By: PTI-18 Aug, 2020

Covid-19, Cold, Flu or Allergy: Know the

By: HT?Correspondent Hindustan Times-17 Aug, 2020

Eat Right, Smile Bright - Acidic Food an

By: FP Studio-17 Aug, 2020

Coronavirus Updates: Karnataka reports 7

By: FP Staff-17 Aug, 2020

Health ID pilot programme to start with

By: FE Online-17 Aug, 2020

Mexico needs 200 million COVID-19 vaccin

By: Reuters-17 Aug, 2020

Factbox: Latest on worldwide coronavirus

By: Reuters-17 Aug, 2020

The Latest: S. Korea reports largest vir

By: The Associated Press-16 Aug, 2020

PM Modi announces launch of National Dig

By: By EH News Bureau-16 Aug, 2020

Russian doctors wary of rapidly approved

By: Reuters-16 Aug, 2020

Need to wage war against NCDs, not just

By: By EH News Bureau-16 Aug, 2020

COVID-19 during pregnancy shows no affec

By: Dr. Liji Thomas-15 Aug, 2020

Has Delhi flattened COVID-19 curve? Wide

By: CitizeMatters.in-15 Aug, 2020

Acupuncture may help with inflammation a

By: Myupchar-15 Aug, 2020

PM Modi to launch National Digital Healt

By: ET Bureau-15 Aug, 2020

WHO says food safe from coronavirus

By: AFP-15 Aug, 2020

Why flu vaccines do not protect people f

By: ScienceMag.org-15 Aug, 2020

Amid Covid-19 fear, Delhi hospital condu

By: ANI-14 Aug, 2020

A new way to monitor skin cancer: Scient

By: Myupchar-14 Aug, 2020

Covid-19: Human trials of Oxford vaccine

By: FE Online-14 Aug, 2020

Coronavirus India Live: Recovery rate in

By: FE Online-14 Aug, 2020

Zydus Cadila launches Indias cheapest re

By: FE Bureau-14 Aug, 2020

NHA governing board gives nod to the int

By: PTI-14 Aug, 2020

ePharmacies to tap approx 70 million Ind

By: EH News Bureau-14 Aug, 2020

Novavax Reports Encouraging Vaccine Resu

By: Carolyn Crist-05 Aug, 2020

"Patients From Outside": Delhi Health Mi

By: DelhiPress Trust of India-09 Aug, 2020

Billion Covid Vaccine Doses Could Be Ava

By: WorldReuters-06 Aug, 2020

New drug RLF-100 shows dramatic recovery

By: PTI-06 Aug, 2020

Biz of this immunity food not in the bes

By: Mayilvaganan-06 Aug, 2020

Views All

Partners & Associates